• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines.警惕在 COVID-19 疫苗临床试验中老年人代表性不足。
Ageing Res Rev. 2021 Dec;72:101486. doi: 10.1016/j.arr.2021.101486. Epub 2021 Oct 18.
2
Reply to "Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines".对《关于新冠病毒疫苗临床试验中老年人代表性不足的警示》的回复。
Ageing Res Rev. 2021 Dec;72:101490. doi: 10.1016/j.arr.2021.101490. Epub 2021 Oct 17.
3
Is COVID-19 really a geriatric syndrome?新冠病毒真的是老年综合征吗？
Ageing Res Rev. 2022 Aug;79:101657. doi: 10.1016/j.arr.2022.101657. Epub 2022 May 29.
4
Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review.COVID-19 疫苗临床试验中老年人代表性不足：一项系统评价。
Ageing Res Rev. 2021 Nov;71:101455. doi: 10.1016/j.arr.2021.101455. Epub 2021 Sep 3.
5
Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years.回复 Hadigal 等人关于≥60 岁成年人中高剂量流感疫苗免疫原性和安全性试验的来信。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2106749. doi: 10.1080/21645515.2022.2106749. Epub 2022 Aug 1.
6
Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.评价由科兴中维生产的新型冠状病毒（灭活）疫苗对医护人员的有效性和安全性的双盲、随机、安慰剂对照 III 期临床试验 - PROFISCOV：一项随机对照试验的研究方案的结构化总结。
Trials. 2020 Oct 15;21(1):853. doi: 10.1186/s13063-020-04775-4.
7
The Rapid Development and Early Success of Covid 19 Vaccines Have Raised Hopes for Accelerating the Cancer Treatment Mechanism.新冠疫苗的快速研发和早期成功为加速癌症治疗机制带来了希望。
Arch Razi Inst. 2021 Mar;76(1):1-6. doi: 10.22092/ari.2021.353761.1612. Epub 2021 Mar 1.
8
Reponse to Letter to The Editor: Regarding: Evaluation of vaccination status of health care workers for recommended vaccines and their acceptance of SARS-CoV-2 vaccines.对致编辑信的回复：关于：医护人员推荐疫苗接种状况及其对SARS-CoV-2疫苗接受情况的评估
Hum Vaccin Immunother. 2022 Nov 30;18(6):2106748. doi: 10.1080/21645515.2022.2106748. Epub 2022 Aug 8.
9
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.一项在已接种 SARS-CoV-2 疫苗的≥75 岁成年人中评估不同 COVID-19 疫苗免疫原性和反应原性的多国、2 期、随机、自适应方案：在 VACCELERATE 网络内开展的一项试验。
Trials. 2022 Oct 8;23(1):865. doi: 10.1186/s13063-022-06791-y.
10
Reply letter to "safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance".回复信：“SARS-CoV-2 疫苗在遗传性果糖不耐受成年患者中的安全性”。
Hum Vaccin Immunother. 2021 Nov 2;17(11):4115-4116. doi: 10.1080/21645515.2021.1959149. Epub 2021 Sep 2.

本文引用的文献

1
Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review.COVID-19 疫苗临床试验中老年人代表性不足：一项系统评价。
Ageing Res Rev. 2021 Nov;71:101455. doi: 10.1016/j.arr.2021.101455. Epub 2021 Sep 3.
2
How to Do a Systematic Review: A Best Practice Guide for Conducting and Reporting Narrative Reviews, Meta-Analyses, and Meta-Syntheses.如何进行系统评价：进行和报告叙述性综述、荟萃分析和荟萃综合的最佳实践指南。
Annu Rev Psychol. 2019 Jan 4;70:747-770. doi: 10.1146/annurev-psych-010418-102803. Epub 2018 Aug 8.
3
Why prospective registration of systematic reviews makes sense.系统评价前瞻性注册为何有意义。
Syst Rev. 2012 Feb 9;1:7. doi: 10.1186/2046-4053-1-7.

警惕在 COVID-19 疫苗临床试验中老年人代表性不足。

Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines.

机构信息

Evidence-Based Medicine Centre, School of Basic Medical Sciences, Lanzhou University, No.199, Donggang West Road, Lanzhou City 730000, Gansu Province, China.

The First Clinical Medical College of Lanzhou University, Lanzhou 730000, China; First Hospital of Lanzhou University, Lanzhou 730000, China.

出版信息

Ageing Res Rev. 2021 Dec;72:101486. doi: 10.1016/j.arr.2021.101486. Epub 2021 Oct 18.

DOI:10.1016/j.arr.2021.101486
PMID:34673261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8522486/
Abstract

We read with great interest the article "Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review" written by Nicola Veronese et al. This important work demonstrated that medications and vaccines commonly used in older adults have not been adequately evaluated. Concerning this systematic review, we shall like to mention some certain points deserved to be attended by the authors.

摘要

我们饶有兴趣地阅读了 Nicola Veronese 等人撰写的题为“COVID-19 疫苗临床试验中老年人代表性不足：系统评价”的文章。这项重要工作表明，老年人常用的药物和疫苗尚未得到充分评估。关于这项系统评价，我们想指出一些作者应该注意的要点。